George Farmer
Stock Analyst
(3.35)
# 3,427
Out of 4,648 analysts
56
Total ratings
32%
Success rate
10.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SAGE Sage Therapeutics | Maintains: Sector Outperform | $17 → $14 | $5.93 | +136.29% | 4 | Oct 30, 2024 | |
| AURA Aura Biosciences | Maintains: Sector Outperform | $20 → $23 | $10.33 | +122.76% | 2 | Oct 18, 2024 | |
| SKYE Skye Bioscience | Initiates: Sector Outperform | $20 | $5.51 | +262.98% | 1 | Sep 30, 2024 | |
| BMEA Biomea Fusion | Maintains: Sector Outperform | $21 → $41 | $9.00 | +355.56% | 3 | Sep 27, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $95 → $78 | $66.25 | +17.74% | 7 | Sep 17, 2024 | |
| INMB INmune Bio | Initiates: Sector Outperform | $22 | $6.13 | +258.89% | 1 | Aug 22, 2024 | |
| LEGN Legend Biotech | Maintains: Sector Outperform | $70 → $76 | $44.14 | +72.18% | 4 | Aug 12, 2024 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $47 → $42 | $56.32 | -25.43% | 2 | Aug 9, 2024 | |
| BIIB Biogen | Maintains: Sector Outperform | $275 → $244 | $174.40 | +39.91% | 2 | Aug 2, 2024 | |
| ADAP Adaptimmune Therapeutics | Initiates: Sector Outperform | $3.15 | $0.82 | +284.62% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $402 → $408 | $587.78 | -30.59% | 4 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $4.00 | +225.00% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $35 | $18.19 | +92.47% | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $0.94 | +1,281.66% | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $36 → $23 | $19.07 | +20.61% | 2 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $66 | $87.83 | -24.85% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Perform | $11 | $17.65 | -40.51% | 1 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $53.92 | +102.15% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $75.83 | +14.74% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $6.43 | +412.87% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $1.20 | +3,233.33% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $34.61 | -21.99% | 3 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $75 | $92.38 | -18.81% | 3 | Apr 29, 2020 |
Sage Therapeutics
Oct 30, 2024
Maintains: Sector Outperform
Price Target: $17 → $14
Current: $5.93
Upside: +136.29%
Aura Biosciences
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $10.33
Upside: +122.76%
Skye Bioscience
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $5.51
Upside: +262.98%
Biomea Fusion
Sep 27, 2024
Maintains: Sector Outperform
Price Target: $21 → $41
Current: $9.00
Upside: +355.56%
BioMarin Pharmaceutical
Sep 17, 2024
Maintains: Sector Perform
Price Target: $95 → $78
Current: $66.25
Upside: +17.74%
INmune Bio
Aug 22, 2024
Initiates: Sector Outperform
Price Target: $22
Current: $6.13
Upside: +258.89%
Legend Biotech
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $44.14
Upside: +72.18%
Janux Therapeutics
Aug 9, 2024
Maintains: Sector Perform
Price Target: $47 → $42
Current: $56.32
Upside: -25.43%
Biogen
Aug 2, 2024
Maintains: Sector Outperform
Price Target: $275 → $244
Current: $174.40
Upside: +39.91%
Adaptimmune Therapeutics
May 30, 2024
Initiates: Sector Outperform
Price Target: $3.15
Current: $0.82
Upside: +284.62%
Mar 26, 2024
Maintains: Sector Perform
Price Target: $402 → $408
Current: $587.78
Upside: -30.59%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $4.00
Upside: +225.00%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $35
Current: $18.19
Upside: +92.47%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $0.94
Upside: +1,281.66%
Jan 31, 2024
Downgrades: Sector Perform
Price Target: $36 → $23
Current: $19.07
Upside: +20.61%
Dec 19, 2023
Initiates: Sector Outperform
Price Target: $66
Current: $87.83
Upside: -24.85%
Jul 27, 2023
Initiates: Sector Perform
Price Target: $11
Current: $17.65
Upside: -40.51%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $53.92
Upside: +102.15%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $75.83
Upside: +14.74%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $6.43
Upside: +412.87%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $1.20
Upside: +3,233.33%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $34.61
Upside: -21.99%
Apr 29, 2020
Maintains: Outperform
Price Target: $89 → $75
Current: $92.38
Upside: -18.81%